Award
NIH Reporter #3U19CA264338-05S1
Advancing treatment and understanding of immunotherapy in glioblastoma
Recipient
University of California, San Francisco
Award Amount
$838,812.00
Ceiling
$838,812.00
Awarded
September 17, 2026
Identifier
3U19CA264338-05S1
A National Cancer Institute grant supplement to support work on immunotherapy in glioblastoma at the University of California, San Francisco.
Description
Supplemental activities within the scope of the parent grant; no changes.